Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Indian Journal of Hematology and Blood Transfusion
Literature
1.
Kostos L, Burbury K, Srivastava G, Prince HM (2015) Gastrointestinal bleeding in a chronic myeloid leukaemia patient precipitated by dasatinib-induced platelet dysfunction: case report. Platelets 26(8):809–811CrossRefPubMed
2.
Mustafa Ali MK, Sabha MM, Al-Rabi KH (2015) Spontaneous subdural hematoma in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia with normal platelet count after dasatinib treatment. Platelets 26(5):491–494CrossRefPubMed
3.
Choi JL, Li S, Han JY (2014) Platelet function tests: a review of progresses in clinical application. BioMed research international. 2014:456569PubMedPubMedCentral
4.
Gora-Tybor J, Medras E, Calbecka M, Kolkowska-Lesniak A, Ponikowska-Szyba E, Robak T et al (2015) Real-life comparison of severe vascular events and other non-hematological complications in patients with chronic myeloid leukemia undergoing second-line nilotinib or dasatinib treatment. Leuk Lymphoma 56(8):2309–2314CrossRefPubMed
5.
Quintas-Cardama A, Han X, Kantarjian H, Cortes J (2009) Tyrosine kinase inhibitor-induced platelet dysfunction in patients with chronic myeloid leukemia. Blood 114(2):261–263CrossRefPubMedPubMedCentral
6.
Haouala A, Widmer N, Duchosal MA, Montemurro M, Buclin T, Decosterd LA (2011) Drug interactions with the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib. Blood 117(8):e75–e87CrossRefPubMed
7.
Bachmair EM, Ostertag LM, Zhang X, de Roos B (2014) Dietary manipulation of platelet function. Pharmacol Ther 144(2):97–113CrossRefPubMed
8.
Abdolahi A, Georas SN, Brenna JT, Cai X, Thevenet-Morrison K, Phipps RP et al (2014) The effects of aspirin and fish oil consumption on lysophosphatidylcholines and lysophosphatidic acids and their correlates with platelet aggregation in adults with diabetes mellitus. Prostaglandins Leukot Essent Fatty Acids 90(2–3):61–68CrossRefPubMed
9.
Takagi Y, Aota Y, Gotoh A, Sakurai M (2010) Effect of low-dose dasatinib in an elderly patient with chronic myelogenous leukemia (CML). Cancer Chemother 37(11):2213–2215
10.
Saito M, Izumiyama K, Mori A, Irie T, Tanaka M, Morioka M et al (2014) Intestinal bleeding in patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors. [Rinsho ketsueki]. Jpn J Clin Hematol 55(1):130–132
Metadata
Title
Dasatinib and Dysfunction of Platelets
Authors
Kamal Kant Sahu
Uday Yanamandra
Vikrant Bhar
Deba Prasad Dhibar
Subhash Chander Varma
Pankaj Malhotra
Publication date
01-06-2016
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue Special Issue 1/2016
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-016-0659-x

Other articles of this Special Issue 1/2016

Indian Journal of Hematology and Blood Transfusion 1/2016 Go to the issue

Case Report

Methimazole Induced Total Myeloid Aplasia with Delayed Recovery Despite Granulocyte Colony Stimulating Factor (G-CSF): Marrow Progenitor Recovery Kinetics

Case Report

A Case Presenting with Splenic Infarct Diagnosed as Primary Bone Marrow CD5 Positive DLBCL: A Clinicopathological Correlation

Case Report

Hyaline-Vascular Type Castleman’s Disease, Sarcoidosis, and Crohns Disease

Case Report

Concurrent Presentation of Therapy Related Acute Myeloid Leukemia in a Case of Neuroblastoma

Correspondence

Significance of Adopting a Sensitive Technique for Donor Antibody Screening

Case Report

Leukemic Transformation of Severe Aplastic Anemia Following Matched Allogenic Stem Cell Transplantation, Transplanted Again in CR 1
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits